Q4 2024 · 13F-HR
Affinity Asset Advisors, LLCholdings as filed
Filed 2025-02-13 · accession 0001839882-25-008942
$746.0M
Reported value
85
Positions
2024-12-31
Period end
Holdings as filed
| CUSIP | Ticker | Issuer | Value | % port. | Shares | Class | Voting |
|---|---|---|---|---|---|---|---|
| 78464A870 | XBI | SPDR SER TR | $67.5M | 9.05% | 750,000 | PUT | SOLE |
| 98420N105 | XENE | XENON PHARMACEUTICALS INC | $45.5M | 6.10% | 1,161,237 | Common | SOLE |
| 03770N101 | APGE | APOGEE THERAPEUTICS INC | $42.2M | 5.66% | 931,728 | Common | SOLE |
| 03940C100 | ACLXGBX | ARCELLX INC | $32.6M | 4.37% | 425,000 | Common | SOLE |
| G01767105 | ALKS | ALKERMES PLC | $31.6M | 4.24% | 1,100,000 | Common | SOLE |
| 881624209 | TEVA | TEVA PHARMACEUTICAL INDS LTD | $30.9M | 4.14% | 1,400,000 | Common | SOLE |
| 925050106 | VRNA | VERONA PHARMA PLC | $30.7M | 4.11% | 660,000 | Common | SOLE |
| 558868105 | MDGL | MADRIGAL PHARMACEUTICALS INC | $25.5M | 3.41% | 82,500 | Common | SOLE |
| 22663K107 | CRNX | CRINETICS PHARMACEUTICALS IN | $23.5M | 3.15% | 460,000 | Common | SOLE |
| 670703107 | NUVL | NUVALENT INC | $22.3M | 2.99% | 285,000 | Common | SOLE |
| 00773J202 | SYRE | SPYRE THERAPEUTICS INC | $19.2M | 2.57% | 824,328 | Common | SOLE |
| Y95308105 | WVE | WAVE LIFE SCIENCES LTD | $18.6M | 2.49% | 1,500,000 | Common | SOLE |
| 152309100 | CNTA | CENTESSA PHARMACEUTICALS PLC | $18.4M | 2.46% | 1,095,924 | Common | SOLE |
| 92337R101 | VERA | VERA THERAPEUTICS INC | $18.0M | 2.41% | 425,000 | Common | SOLE |
| 67080M103 | NRIX | NURIX THERAPEUTICS INC | $17.7M | 2.37% | 940,083 | Common | SOLE |
| 590717401 | MESO | MESOBLAST LTD | $16.6M | 2.23% | 838,600 | PUT | SOLE |
| N5749R100 | 2GH | MERUS N V | $16.4M | 2.19% | 389,241 | Common | SOLE |
| 19249HAB9 | — | COHERUS BIOSCIENCES INC | $16.2M | 2.17% | 16,625,000 | Common | SOLE |
| 682143AG7 | OMER 5.25 02/15/26 | OMEROS CORP | $14.6M | 1.96% | 15,525,000 | Common | SOLE |
| G31249108 | ESTA | ESTABLISHMENT LABS HLDGS INC | $12.9M | 1.73% | 279,445 | Common | SOLE |
| 04335A105 | ARVN | ARVINAS INC | $12.1M | 1.62% | 630,000 | Common | SOLE |
| 48576UAA4 | — | KARYOPHARM THERAPEUTICS INC | $11.9M | 1.59% | 15,250,000 | Common | SOLE |
| 45790W108 | — | INOZYME PHARMA INC | $11.0M | 1.47% | 3,972,318 | Common | SOLE |
| N62509109 | NAMS | NEWAMSTERDAM PHARMA COMPANY | $10.9M | 1.46% | 425,000 | Common | SOLE |
| 05280R100 | AUTL | AUTOLUS THERAPEUTICS PLC | $10.6M | 1.42% | 4,500,000 | Common | SOLE |
| 374163103 | GERN | GERON CORP | $8.0M | 1.07% | 2,250,000 | Common | SOLE |
| 031162100 | AMGN | AMGEN INC | $7.8M | 1.05% | 30,000 | CALL | SOLE |
| 76200L309 | RZLT | REZOLUTE INC | $7.7M | 1.03% | 1,575,000 | Common | SOLE |
| N71542109 | PRQR | PROQR THRAPEUTICS N V | $7.5M | 1.00% | 2,825,000 | Common | SOLE |
| 687604108 | ORKA | ORUKA THERAPEUTICS INC | $7.1M | 0.96% | 368,698 | Common | SOLE |
| 05464T104 | AXSM | AXSOME THERAPEUTICS INC | $6.3M | 0.85% | 75,000 | Common | SOLE |
| 29479A108 | ERAS | ERASCA INC | $6.3M | 0.84% | 2,499,431 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $5.8M | 0.78% | 130,000 | Common | SOLE |
| 89422GAA5 | TVTX 2.25 03/01/29 | TRAVERE THERAPEUTICS INC | $5.7M | 0.77% | 6,000,000 | Common | SOLE |
| 04280A100 | ARWR | ARROWHEAD PHARMACEUTICALS IN | $5.6M | 0.76% | 300,000 | Common | SOLE |
| 10806X102 | BBIO | BRIDGEBIO PHARMA INC | $5.5M | 0.74% | 200,000 | Common | SOLE |
| 640979100 | NMRA | NEUMORA THERAPEUTICS INC. | $5.0M | 0.67% | 475,000 | CALL | SOLE |
| 74366E102 | PTGX | PROTAGONIST THERAPEUTICS INC | $5.0M | 0.67% | 130,000 | Common | SOLE |
| 603170101 | MLYS | MINERALYS THERAPEUTICS INC | $4.3M | 0.58% | 350,000 | Common | SOLE |
| 46489V302 | CATX | PERSPECTIVE THERAPEUTICS INC | $4.1M | 0.56% | 1,300,000 | Common | SOLE |
| 14817C107 | FLNA | CASSAVA SCIENCES INC | $4.1M | 0.55% | 1,739,400 | PUT | SOLE |
| 05338F306 | AVTX | AVALO THERAPEUTICS INC | $4.1M | 0.55% | 550,765 | Common | SOLE |
| G70077105 | PCSC | PERCEPTIVE CAP SOLUTIONS COR | $3.6M | 0.48% | 350,000 | Common | SOLE |
| 89422G107 | TVTX | TRAVERE THERAPEUTICS INC | $3.5M | 0.47% | 200,000 | Common | SOLE |
| 457669307 | INSM | INSMED INC | $3.5M | 0.46% | 50,000 | Common | SOLE |
| N62509117 | NAMSW | NEWAMSTERDAM PHARMA COMPANY | $3.3M | 0.45% | 237,935 | Common | SOLE |
| 20451W101 | CMPS | COMPASS PATHWAYS PLC | $3.2M | 0.43% | 850,512 | Common | SOLE |
| 363225202 | GALT | GALECTIN THERAPEUTICS INC | $3.2M | 0.43% | 2,492,000 | PUT | SOLE |
| 230031106 | CGEM | CULLINAN THERAPEUTICS INC | $3.2M | 0.43% | 263,817 | Common | SOLE |
| 92790C104 | VRDN | VIRIDIAN THERAPEUTICS INC | $3.1M | 0.41% | 159,614 | Common | SOLE |
| 604749101 | MIRM | MIRUM PHARMACEUTICALS INC | $2.9M | 0.39% | 70,742 | Common | SOLE |
| 156944100 | CGON | CG ONCOLOGY INC | $2.9M | 0.38% | 100,000 | Common | SOLE |
| 878972108 | TECX | TECTONIC THERAPEUTIC INC | $2.7M | 0.36% | 58,331 | Common | SOLE |
| G4444H101 | BBOT | HELIX ACQUISITION CORP II | $2.6M | 0.35% | 250,000 | Common | SOLE |
| G6717R120 | OACCU | OAKTREE ACQUISITION CORP III | $2.5M | 0.34% | 250,000 | Common | SOLE |
| 45258J102 | IMVT | IMMUNOVANT INC | $2.5M | 0.33% | 100,000 | Common | SOLE |
| 008064107 | — | AEROVATE THERAPEUTICS INC | $2.1M | 0.28% | 800,000 | Common | SOLE |
| 92243G108 | PCVX | VAXCYTE INC | $2.0M | 0.27% | 25,000 | Common | SOLE |
| 65487U108 | NKTX | NKARTA INC | $2.0M | 0.27% | 800,000 | Common | SOLE |
| 65343E108 | NXTCEUR | NEXTCURE INC | $1.8M | 0.24% | 2,302,598 | Common | SOLE |
| 03675P102 | AVR | ANTERIS TECHNOLOGIES GLOBAL | $1.7M | 0.22% | 300,000 | Common | SOLE |
| 501575104 | KYMR | KYMERA THERAPEUTICS INC | $1.6M | 0.22% | 40,000 | Common | SOLE |
| 03753U106 | APLSUSD | APELLIS PHARMACEUTICALS INC | $1.6M | 0.21% | 50,000 | Common | SOLE |
| 75382E109 | — | RAPT THERAPEUTICS INC | $1.6M | 0.21% | 1,000,000 | Common | SOLE |
| 45332Y109 | NARIUSD | INARI MED INC | $1.3M | 0.17% | 25,000 | Common | SOLE |
| 805111101 | SVRA | SAVARA INC | $1.3M | 0.17% | 410,586 | Common | SOLE |
| 68277Q105 | OKUR | ONKURE THERAPEUTICS INC | $1.2M | 0.17% | 144,159 | Common | SOLE |
| 09203E105 | BDTX | BLACK DIAMOND THERAPEUTICS I | $1.2M | 0.16% | 559,163 | Common | SOLE |
| 21077P108 | CNTX | CONTEXT THERAPEUTICS INC | $1.1M | 0.14% | 1,015,340 | Common | SOLE |
| 49372L209 | 2KZ0 | KEZAR LIFE SCIENCES INC | $956,364 | 0.13% | 142,316 | Common | SOLE |
| 28658R106 | CLYM | CLIMB BIO INC | $900,000 | 0.12% | 500,000 | Common | SOLE |
| 75041J101 | RADX | RADIOPHARM THERANOSTICS LTD | $684,029 | 0.09% | 156,171 | Common | SOLE |
| 45256X103 | IBRX | IMMUNITYBIO INC | $640,000 | 0.09% | 250,000 | PUT | SOLE |
| 09077A106 | BMEA | BIOMEA FUSION INC | $582,000 | 0.08% | 150,000 | PUT | SOLE |
| G9TY5A101 | ZURA | ZURA BIO LTD | $558,338 | 0.07% | 223,335 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $354,168 | 0.05% | 1,541,200 | PUT | SOLE |
| 15117B202 | CLDX | CELLDEX THERAPEUTICS INC NEW | $252,498 | 0.03% | 9,992 | Common | SOLE |
| 00534B100 | ADGM | ADAGIO MED HLDGS INC | $223,897 | 0.03% | 213,235 | Common | SOLE |
| 760273102 | RPTX | REPARE THERAPEUTICS INC | $131,000 | 0.02% | 100,000 | Common | SOLE |
| 682143102 | OMER | OMEROS CORP | $98,385 | 0.01% | 9,958 | Common | SOLE |
| 746964105 | QTTB | Q32 BIO INC | $95,553 | 0.01% | 27,777 | Common | SOLE |
| N44445117 | IMTXW | IMMATICS N.V | $47,082 | 0.01% | 187,204 | Common | SOLE |
| 87184Q206 | SYRS | SYROS PHARMACEUTICALS INC | $34,470 | 0.00% | 150,000 | Common | SOLE |
| 834203309 | SLNO | SOLENO THERAPEUTICS INC | $8,990 | 0.00% | 200 | CALL | SOLE |
| 77313F114 | RCKTW | ROCKET PHARMACEUTICALS INC | $2,573 | 0.00% | 75,000 | Common | SOLE |
Source: SEC EDGAR · raw 13F holdings as filed. The Class column shows the option type when reported (Put/Call) or Common when the issuer's equity is held directly. 13F discloses long positions only.